Data as of Q4 2025 (Dec 31, 2025)

DAFNA Capital Management LLC

โ€ขCIK: 1389933โ€ขFiling: Q4 2025

**DAFNA Capital Management LLC** manages $431M across a concentrated portfolio of 77 positions. The fund exhibits significant conviction in specific sectors, highlighted by its top holdings including RVMD at $48.1M and XBI at $41.0M. Further substantial allocations are noted in RJR1 ($31.5M) and ATRC/CYTK, each representing $23.6M. This positioning suggests a tactical, high-conviction approach targeting specific market opportunities.

Total AUM
$425.1M
QoQ Performance
+6.4%
Positions
76
Top 10 Concentration
55.6%
Latest Filing
Q4 2025

Top Holdings Allocation

RVMD
XBI
RJR1
ATRC
CYTK
RVMD11.3%
XBI9.7%
RJR17.4%
ATRC5.6%
CYTK5.5%
IDYA4.1%
AXGN3.7%
XENE3.0%

๐Ÿ“ˆ Biggest Buys

BHVN
BIOHAVEN LTD
+306.1%
2.5% of portfolio
PRCT
PROCEPT BIOROBOTICS CORP
NEW
0.9% of portfolio
HELP
CYBIN INC
NEW
0.9% of portfolio
MBX
MBX BIOSCIENCES INC
+94.4%
1.2% of portfolio
MPLT
MAPLIGHT THERAPEUTICS INC
NEW
0.6% of portfolio

๐Ÿ“‰ Biggest Sells

AXGN
AXOGEN INC
-35.8%
3.7% of portfolio
XBI
SPDR S&P BIOTECH ETF
-16.2%
9.7% of portfolio
IBB
ISHARES NASDAQ BIOTECH INDX
-33.6%
2.7% of portfolio
SNDX
SYNDAX PHARMACEUTICALS INC
-44.5%
1.4% of portfolio
RCUS
ARCUS BIOSCIENCES INC
-31.3%
2.4% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

2GH
MERUS BV
SOLD
$20.8M
SLNO
SOLENO THERAPEUTICS INC
SOLD
$3.6M
CMPX
COMPASS THERAPEUTICS INC
SOLD
$3.3M
KRRO
KORRO BIO INC
SOLD
$2.9M
KROS
KEROS THERAPEUTICS INC
SOLD
$1.3M
+5 more exited positions

Changes from Q3 2025

NEW12 new positions
โ†‘16 increased
โ†“29 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023